On March 2, 2020 Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) technology, reported that its chief executive officer, David Giljohann, will give a company update on Wednesday, March 4, 2020 at 11:20 AM ET at the Cowen 40th Annual Healthcare Conference in Boston (Press release, Exicure, MAR 2, 2020, http://investors.exicuretx.com/news-releases/news-release-details/exicure-present-cowen-40th-annual-healthcare-conference [SID1234555019]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation and Breakout Session Details:

Cowen 40th Annual Health Care Conference
Date: Wednesday, March 4, 2020
Presentation Time: 11:20-11:50 AM Eastern Time

A live audio webcast will be available on the Investors section of Exicure’s website: www.exicuretx.com. The webcast will be archived for approximately 30 days following the event.